Fenofibrate therapy and risk of heart failure outcomes in patients with type 2 diabetes: a propensity-matched cohort study [0.03%]
泛他茋治疗2型糖尿病患者的心力衰竭结局：一项倾向匹配队列研究
Ji Yoon Kim,Nam Hoon Kim,Jiyoon Lee et al.
Ji Yoon Kim et al.
Aims: This study investigated the association between fenofibrate use and outcomes of heart failure (HF) in patients with type 2 diabetes (T2D). Methods a...
Marco Cattaneo
Marco Cattaneo
Single versus Dual Antiplatelet Therapy in Patients with Severe Peripheral Arterial Disease Undergoing TAVI: Insights from The Hostile Registry [0.03%]
重度外周动脉疾病行TAVI患者的单联与双联抗血小板治疗：HOSTILE登记研究的新见解
Mattia Galli,Roberto Nerla,Fausto Castriota et al.
Mattia Galli et al.
Aims: Single antiplatelet therapy (SAPT) has been shown to be a safer alternative to dual antiplatelet therapy (DAPT) in patients without atrial fibrillation undergoing transcatheter aortic valve implantation (TAVI). Howe...
Nonsteroidal Mineralocorticoid Receptor Antagonists and Cardiovascular Events in Type 2 Diabetes: A Retrospective Study [0.03%]
非甾体类盐皮质激素受体拮抗剂与2型糖尿病患者的心血管事件：一项回顾性研究
Yi-Hsien Chen,Yu-Wei Fang,Mon-Ting Chen et al.
Yi-Hsien Chen et al.
Aims: Nonsteroidal mineralocorticoid receptor antagonists such as finerenone mitigate cardiorenal risks in patients with type 2 diabetes mellitus (T2DM). Real-world evidence comparing finerenone with spironolactone and ep...
SGLT2 inhibitors and Mortality in Diabetic Cancer Patients. Cardioprotective and Anticancer effects [0.03%]
钠-葡萄糖协同转运蛋白2抑制剂与糖尿病患者的死亡率及心血管保护和抗癌作用
Kalliopi Keramida,Ali Ahmed,Gerasimos Filippatos
Kalliopi Keramida
Uwe Zeymer,Tobias Geisler,Dirk Westermann et al.
Uwe Zeymer et al.
Dual antiplatelet therapy with acetylsalicylic acid (ASA) and an oral P2Y12 inhibitor is the standard of care to prevent thrombotic complications in patients with acute coronary syndromes undergoing percutaneous coronary intervention (PCI)....
Prevention of atrial fibrillation with SGLT2 inhibitors across the spectrum of cardiovascular disorders: a meta-analysis of randomised controlled trials [0.03%]
钠-葡萄糖协同转运蛋白2抑制剂预防心血管疾病患者房颤的疗效：随机对照试验的meta分析研究
Damiano Fedele,Marcello Casuso Alvarez,Angelo Maida et al.
Damiano Fedele et al.
Aims: The ability of sodium-glucose cotransporter-2 (SGLT2) inhibitors to prevent atrial fibrillation (AF) has been evaluated in various studies with conflicting results. This study aimed to determine whether SGLT2 inhibi...